‘This is a low-cost peoples’ vaccine:’ Expert on India’s Biological E vaccine

Posted by & filed under Part 1 Business in a Global Environment, Part 3 Management: Empowering People to Achieve Business Objectives, Part 4: Marketing Management, Part 5 Managing Technology and Information, Part 6 Managing Financial Resources.

Description: Johnson & Johnson (JNJ) is getting lots of help both at home and abroad to get its COVID-19 jab out to the masses.
In the U.S., Merck (MRK) stepped up to begin the process this month, while in Europe, Sanofi (SNY) has offered to help fill and finish vials. And in India, J&J has already partnered with the world’s largest vaccine maker, the Serum Institute of India.

Source: Yahoo.Finance.com – video report

Date: Mar 22, 2021

Link: https://ca.finance.yahoo.com/news/us-supports-indias-biological-e-adding-to-global-supply-of-covid-19-vaccines-160331441.html

Questions for discussion:

  • Describe the global relationships between governments and the pharmaceutical industry.
  • Is this structure a good or bad thing for vaccine production and distribution, in your opinion?

Leave a Reply